Rock Springs Capital Management’s Pliant Therapeutics PLRX Stock Holding History

Rock Springs Capital Management’s Portfolio PLRX Stock Details PLRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-589,996	Closed	-$796K	–	99
2025 Q1	$796K	Buy	589,996 +185,200	+46%	+$1.12M	0.05%	91
2024 Q4	$5.33M	Buy	404,796 +19,800	+5%	+$270K	0.2%	75
2024 Q3	$4.32M	Hold	384,996	–	–	0.14%	86
2024 Q2	$4.14M	Hold	384,996	–	–	0.12%	89
2024 Q1	$5.74M	Hold	384,996	–	–	0.15%	91
2023 Q4	$6.97M	Sell	384,996 -106,225	-22%	-$1.62M	0.17%	80
2023 Q3	$8.52M	Hold	491,221	–	–	0.23%	77
2023 Q2	$8.9M	Hold	491,221	–	–	0.21%	78
2023 Q1	$13.1M	Buy	+491,221	New	+$14M	0.31%	70

Other funds holding PLRX

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BOCH

Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

TGI

TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

Rock Springs Capital Management's PLRX Position: Q2 2025 in Review

Rock Springs Capital Management sold out of Pliant Therapeutics (PLRX) in Q2 2025, closing a stake of 589,996 shares — an estimated $796K sold.

Rock Springs Capital Management first reported a position in PLRX in Q1 2023 and held it in 9 quarters. The position peaked at $13.1M in Q1 2023. 114 funds tracked by Wall St. Rank hold PLRX as of Q2 2025.

Rock Springs Capital Management reported no remaining Pliant Therapeutics position as of Q2 2025 after selling out during the quarter.
Rock Springs Capital Management sold 589,996 Pliant Therapeutics shares in Q2 2025, an estimated $796K.
Rock Springs Capital Management first reported a position in Pliant Therapeutics in Q1 2023 and held it in 9 quarters.
Rock Springs Capital Management's Pliant Therapeutics position peaked at $13.1M in Q1 2023.
114 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q2 2025.

Based on Rock Springs Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.